HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chao Zhao Selected Research

ErbB Receptors (EGF Receptor)

4/2024Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer.
1/2022EGFR amplification is a putative resistance mechanism for NSCLC-LM patients with TKI therapy and is associated with poor outcome.
8/2020The impact of EGFR exon 19 deletion subtypes on clinical outcomes in non-small cell lung cancer.
1/2020Soluble PD-L1 as a Predictor of the Response to EGFR-TKIs in Non-small Cell Lung Cancer Patients With EGFR Mutations.
1/2020Uncommon EGFR mutations associate with lower incidence of T790M mutation after EGFR-TKI treatment in patients with advanced NSCLC.
1/2020Association of CD8 T cell apoptosis and EGFR mutation in non-small lung cancer patients.
11/2019Highly sensitive and specific screening of EGFR mutation using a PNA microarray-based fluorometric assay based on rolling circle amplification and graphene oxide.
11/2019EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in patients with EGFR-mutant NSCLC and multiple brain metastases.
1/2019Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients Treated With First-Line EGFR Tyrosine Kinase Inhibitors.
11/2018Impact of serum vascular endothelial growth factor and interleukin-6 on treatment response to epidermal growth factor receptor tyrosine kinase inhibitors in patients with non-small-cell lung cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chao Zhao Research Topics

Disease

100Neoplasms (Cancer)
05/2024 - 01/2008
61Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 01/2013
39Demyelinating Diseases (Demyelinating Disease)
01/2024 - 04/2002
26Infections
02/2024 - 10/2007
25Inflammation (Inflammations)
04/2024 - 09/2006
19Lung Neoplasms (Lung Cancer)
05/2024 - 08/2013
17Neoplasm Metastasis (Metastasis)
06/2023 - 11/2005
13Type 2 Diabetes Mellitus (MODY)
12/2023 - 08/2002
12Carcinogenesis
05/2023 - 11/2005
12Multiple Sclerosis
01/2021 - 03/2006
11Wounds and Injuries (Trauma)
01/2024 - 11/2013
11Alzheimer Disease (Alzheimer's Disease)
01/2022 - 03/2010
10Adenocarcinoma of Lung
01/2024 - 01/2014
10Hepatocellular Carcinoma (Hepatoma)
10/2023 - 04/2009
9Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2024 - 04/2013
9Pain (Aches)
01/2023 - 01/2013
8Body Weight (Weight, Body)
03/2022 - 05/2014
8Disease Progression
07/2021 - 11/2013
7Breast Neoplasms (Breast Cancer)
12/2023 - 04/2012
7Brain Neoplasms (Brain Tumor)
11/2023 - 10/2016
7Hyperglycemia
09/2023 - 05/2014
6Esophageal Neoplasms (Esophageal Cancer)
01/2024 - 11/2019
6Adenocarcinoma
10/2022 - 07/2014
6Bacterial Infections (Bacterial Infection)
01/2022 - 08/2002
6Endometrial Neoplasms (Endometrial Cancer)
12/2015 - 06/2005
5Glioma (Gliomas)
04/2024 - 01/2019
5Obesity
06/2023 - 08/2017
5Carcinoma (Carcinomatosis)
05/2023 - 09/2013
5Ischemic Stroke
01/2023 - 01/2019
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2023 - 10/2014
5Hyperlipidemias (Hyperlipidemia)
01/2023 - 09/2013
5Parkinson Disease (Parkinson's Disease)
10/2022 - 01/2020
5Esophageal Squamous Cell Carcinoma
10/2022 - 10/2014
5Edema (Dropsy)
01/2022 - 09/2011
5Brain Ischemia (Cerebral Ischemia)
01/2022 - 03/2017
5Colorectal Neoplasms (Colorectal Cancer)
11/2020 - 09/2010
4Dysbiosis
01/2024 - 01/2019
4Neuralgia (Stump Neuralgia)
04/2023 - 01/2017
4Fibrosis (Cirrhosis)
01/2023 - 01/2021
4Persistent Infection
12/2022 - 12/2019
4Brain Injuries (Brain Injury)
05/2022 - 03/2017
4Virus Diseases (Viral Diseases)
10/2021 - 09/2011
4Hypoxia (Hypoxemia)
07/2021 - 12/2011
4Circulating Neoplastic Cells
05/2020 - 08/2015
4Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2019 - 01/2005

Drug/Important Bio-Agent (IBA)

29Biomarkers (Surrogate Marker)IBA
04/2024 - 11/2005
28Proteins (Proteins, Gene)FDA Link
04/2024 - 11/2007
22ErbB Receptors (EGF Receptor)IBA
04/2024 - 08/2013
19Tyrosine Kinase InhibitorsIBA
08/2020 - 08/2013
16Immune Checkpoint InhibitorsIBA
06/2023 - 01/2018
13Glucose (Dextrose)FDA LinkGeneric
11/2023 - 08/2002
12LigandsIBA
10/2021 - 09/2006
12Messenger RNA (mRNA)IBA
01/2021 - 04/2002
11VaccinesIBA
12/2024 - 01/2011
11LipidsIBA
01/2024 - 01/2018
11Polysaccharides (Glycans)IBA
12/2023 - 10/2014
10EnzymesIBA
01/2024 - 09/2011
9RNA (Ribonucleic Acid)IBA
05/2024 - 01/2015
9MicroRNAs (MicroRNA)IBA
01/2024 - 10/2014
9Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
02/2023 - 02/2005
9Therapeutic UsesIBA
10/2022 - 12/2017
8AntioxidantsIBA
04/2024 - 05/2014
8NitrosaminesIBA
05/2023 - 11/2019
8Peptides (Polypeptides)IBA
01/2020 - 03/2010
7Interleukin-6 (Interleukin 6)IBA
01/2023 - 08/2016
7Long Noncoding RNAIBA
09/2022 - 02/2015
7Transcription Factors (Transcription Factor)IBA
04/2018 - 04/2002
6Reactive Oxygen Species (Oxygen Radicals)IBA
04/2024 - 04/2019
6Oxygen (Dioxygen)IBA
10/2023 - 02/2015
6Blood Glucose (Blood Sugar)IBA
05/2023 - 05/2014
6AcidsIBA
01/2023 - 01/2008
6CytokinesIBA
12/2022 - 09/2006
6DNA (Deoxyribonucleic Acid)IBA
11/2022 - 01/2008
5Fatty Acids (Saturated Fatty Acids)IBA
02/2024 - 06/2009
5Antiviral Agents (Antivirals)IBA
02/2024 - 01/2019
5Hypoglycemic Agents (Hypoglycemics)IBA
12/2023 - 07/2020
5OligosaccharidesIBA
06/2023 - 10/2014
5CelluloseIBA
04/2023 - 11/2021
5Indocyanine Green (Cardio-Green)FDA LinkGeneric
04/2023 - 05/2018
5AntibodiesIBA
12/2022 - 01/2019
5Phosphotransferases (Kinase)IBA
01/2022 - 09/2005
5Amyloid (Amyloid Fibrils)IBA
01/2020 - 09/2011
4osimertinibIBA
04/2024 - 01/2019
4Antimicrobial PeptidesIBA
09/2023 - 12/2013
4Environmental CarcinogensIBA
05/2023 - 03/2022
4Papillomavirus Vaccines (HPV Vaccines)IBA
01/2023 - 12/2019
4Interleukin-10 (Interleukin 10)IBA
12/2022 - 12/2011
4CopperIBA
10/2022 - 02/2014
4Formaldehyde (Formol)FDA Link
06/2021 - 02/2015
4bis(4-hydroxyphenyl)sulfoneIBA
01/2021 - 01/2018
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 11/2018
4Folic Acid (Vitamin M)FDA LinkGeneric
05/2020 - 08/2015
4Anaplastic Lymphoma KinaseIBA
01/2019 - 06/2014

Therapy/Procedure

67Therapeutics
04/2024 - 03/2006
22Drug Therapy (Chemotherapy)
01/2023 - 01/2014
9Immunotherapy
01/2023 - 01/2018
7Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 04/2015
4Transplantation
01/2024 - 01/2013
4Photothermal Therapy
01/2023 - 01/2021
4Lasers (Laser)
01/2021 - 11/2015